Please provide your email address to receive an email when new articles are posted on . Based on these risk factors, providers should prolong their monitoring of these patients, Terence Langlois, ...

Adequacy of biopsy samples for molecular testing in patients with non-small cell lung cancer. Analyses of the immunologically relevant gene transcript by qRT-PCR in primary cutaneous melanoma by the ...

Reference ranges for basal serum tryptase (BST) are an excellent guide to determining whether a patient’s BST value is normal, per their specific tryptase genotype. If the BST is elevated based on the ...

—An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase levels and stings from certain ...

56% mean improvement in Total Symptom Score (TSS) at 24 weeks with 76% of patients achieving at least a 50% reduction in TSS 89% of patients had >50% decrease in serum tryptase by four weeks of ...

Cogent Biosciences (COGT) announced updated clinical results from the Open Label Extension OLE, portion of SUMMIT, a clinical trial evaluating bezuclastinib in patients with nonadvanced systemic ...

Please provide your email address to receive an email when new articles are posted on . Evidence of systemic mast cell activation in the PROSPECTOR study was split into three categories. A REMA score ...

--Data strongly support expanding development into mast cell driven diseases-- --Data presented in a late-breaking session at EAACI Annual Congress 2020-- HAMPTON, N.J., June 06, 2020 (GLOBE NEWSWIRE) ...